d1466a85-90fb-4042-be95-40bd0d9b40fd.png?sfvrsn=8f0f5f55_1)
Roadmaps to the Intertwined IP and Regulatory Regimes in China
May 13, 2020 9:00 AM to 10:00 AM
Location
Virtual - all times are eastern daylight time
Credits
60 Minutes of MCLE
Moderator: Jeremy K. McKown, Janssen R&D, New Brunswick, NJ
Topics
Developments in pharmaceutical IP and regulatory coordination efforts to stimulate faster and better pharmaceutical development in ChinaJuhua Luo, CCPIT Patent and Trademark Law Office, Beijing, China
Using Patent Law and Policy for Incentivizing Green Technology Innovation in China
Wen Cao, Principal of Shanghai Office of NTD, Shanghai, China
Presented by the IP Practice in China Committee and the US Group of AIPPI
Speakers
-
Luo, Juhua
CCPIT Patent and Trademark Law Office
Mr. Luo's practice focuses mainly on prosecution of patent. -
McKown, Jeremy K.
Janssen R&D at Johnson & Johnson | Vice President of Law
Jeremy is a Vice-President at Janssen R&D, a Johnson & Johnson affiliate (J&J), where he manages a global team of attorneys and professionals focused on drafting and negotiating complex agreements related to J&J's pharmaceutical business. -
Cao, Wen
Shanghai Office of NTD | Senior Partner
Ms. Cao serves as the principal of NTD Shanghai Office.